Bank Of America Corp Mesoblast LTD Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.39 $13,247 - $18,413	13,247 Added 646.51%	15,296 $16,000
Q2 2023 Aug 14, 2023	BUY	$2.95 - $4.44 $4,643 - $6,988	1,574 Added 331.37%	2,049 $8,000
Q1 2023 May 12, 2023	BUY	$2.94 - $4.18 $1,370 - $1,947	466 Added 5177.78%	475 $1,000
Q4 2022 Feb 10, 2023	SELL	$2.73 - $3.7 $1,777 - $2,408	-651 Reduced 98.64%	9 $0
Q3 2022 Nov 14, 2022	SELL	$0.48 - $3.48 $588 - $4,263	-1,225 Reduced 64.99%	660 $2,000
Q2 2022 Aug 12, 2022	BUY	$2.22 - $4.54 $2,204 - $4,508	993 Added 111.32%	1,885 $4,000
Q1 2022 May 16, 2022	SELL	$3.58 - $4.98 $42,473 - $59,082	-11,864 Reduced 93.01%	892 $4,000
Q4 2021 Feb 08, 2022	SELL	$4.17 - $7.09 $117,072 - $199,051	-28,075 Reduced 68.76%	12,756 $61,000
Q3 2021 Nov 15, 2021	SELL	$5.87 - $7.85 $803,438 - $1.07 Million	-136,872 Reduced 77.02%	40,831 $245,000
Q2 2021 Sep 13, 2021	BUY	$6.69 - $9.0 $1.19 Million - $1.6 Million	177,703 New	177,703 $1.33 Million

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.